Genomtec commercializes its first genetic laboratory kit for rapid detection of SARS-CoV-2

Genomtec® SARS-CoV-2 RT-LAMP/N CE-IVD laboratory kit is our first product in the SARS-CoV-2 pipeline. After just over 10 weeks of hard work we ... More

MicroRNA-based tool for non-invasive early-stage cancer diagnosis — GenomtecTumor

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 885874 The ... More

Genomtec takes fast track forward

After approved financing of almost 2.5 million USD from National Center for Research and Development as a non-dilutive grant Genomtec further ... More

Genomtec ID among the finalists of the Biomed PFR Academy

Yesterday, the PFR BioMed Academy closing gala was held, where 15 innovative companies presented their unique ideas. What is more, the jury of ... More

GENOMTEC is the winner of the Next Health Investment Pitch competition organized by Amgen and ImpactCEE

Warsaw, (23 May 2019) – Amgen and ImpactCEE announced the winner of the Next Health Investment Pitch. Genomtec, the creator of innovative ... More

Operational Program: Intelligent Development 2014-2020 – “Fast Track”

Project title: Development of technology and mobile diagnostic equipment based on the lab-on-chip solution for detecting infectious diseases ... More